Clonazepam Tablet Shortage: Current FDA Status
Areazine synthesizes this FDA drug-shortage notice directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Clonazepam Tablet is currently listed in the FDA Drug Shortages Database, with availability from the manufacturer, first posted on March 10, 2023.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on April 7, 2026 and geographically references United States. Its severity classification of "low" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, Clonazepam.
What's in Shortage
The generic drug Clonazepam Tablet, also known by the brand name KLONOPIN, is currently in shortage status as per the FDA. It is available in tablet dosage form and belongs to therapeutic categories including Neurology, Pediatric, and Psychiatry. The shortage was initially posted on March 10, 2023, and last updated on April 1, 2026.
Which Manufacturers Are Affected
The manufacturer Cheplapharm Arzneimittel GmbH, marketed by H2-Pharma, reports the following availability:
- Klonopin, Tablet, 0.5 mg (NDC 61269-605-10): Available
- Klonopin, Tablet, 1 mg (NDC 61269-610-10): Available
- Klonopin, Tablet, 2 mg (NDC 61269-620-10): Available Contact information for the manufacturer is orders@h2-pharma.com.
Why There's a Shortage
No specific reason for the shortage was provided in the FDA database.
What Patients Should Do
Patients who depend on Clonazepam Tablet should talk to their pharmacist or healthcare provider to check on availability and next steps. They may also contact the manufacturer directly using the provided information. Please note that patients should always consult their healthcare provider for any medication-related concerns and not make changes without professional advice.
Source
This information is attributed to the FDA Drug Shortages Database.
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA drug-shortage notice: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,318 characters here).
Similar severity timing
Same severity (low) notices issued closest in time to April 7, 2026.
Frequently Asked Questions
Common questions about this FDA drug-shortage notice.